Stockscreener 앱 받기
35.52
0.91%
0.32
시간 외 거래:
35.52
전일 마감가:
$35.20
열려 있는:
$35.44
하루 거래량:
309.71K
Relative Volume:
0.72
시가총액:
$1.15B
수익:
$796.33M
순이익/손실:
$74.95M
주가수익비율:
17.39
EPS:
2.0427
순현금흐름:
$329.83M
1주 성능:
-0.06%
1개월 성능:
-2.92%
6개월 성능:
-21.62%
1년 성능:
+11.77%
1일 변동 폭
$35.26
$36.03
1주일 범위
$34.00
$36.51
52주 변동 폭
$29.19
$50.79
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
명칭
Collegium Pharmaceutical Inc
전화
781-713-3699
주소
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Compare COLL vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
35.52 | 1.14B | 796.33M | 74.95M | 329.83M | 2.0427 |
TAK
Takeda Pharmaceutical Co Adr
|
17.44 | 55.06B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.94 | 43.07B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.08 | 35.88B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
76.92 | 31.59B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
527.94 | 26.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-01-10 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-05-10 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-10 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-08-25 | 재확인 | Needham | Buy |
| 2023-05-02 | 재개 | Jefferies | Buy |
| 2022-08-08 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-14 | 개시 | BWS Financial | Sell |
| 2020-05-27 | 개시 | Guggenheim | Neutral |
| 2020-02-19 | 재개 | Jefferies | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-05-03 | 재개 | H.C. Wainwright | Buy |
| 2019-04-12 | 재개 | Janney | Buy |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-01-16 | 재확인 | Needham | Buy |
| 2018-03-08 | 재확인 | H.C. Wainwright | Buy |
| 2018-02-07 | 재확인 | Needham | Buy |
| 2017-12-05 | 재확인 | Needham | Buy |
| 2017-09-11 | 개시 | H.C. Wainwright | Buy |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-09-13 | 개시 | Gabelli & Co | Buy |
| 2015-06-01 | 개시 | Jefferies | Buy |
| 2015-06-01 | 개시 | Needham | Buy |
| 2015-06-01 | 개시 | Piper Jaffray | Overweight |
모두보기
Collegium Pharmaceutical Inc 주식(COLL)의 최신 뉴스
Winners And Losers Of Q1: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance
Collegium Pharmaceutical Inc (COLL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Collegium Pharmaceutical Inc (COLL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Collegium Pharmaceutical, Inc. Revenue Breakdown – FWB:354 - TradingView
Collegium Pharmaceutical Inc (COLL) Institutional Confidence - TradingKey
Collegium Pharmaceutical, Inc. Revenue Breakdown – BOATS:COLL - TradingView
Collegium Pharmaceutical Inc (COLL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Collegium Pharmaceutical stock gains 2.46% as CollegiumPharma schedules Q2 results call for August 6 - Traders Union
Collegium's Aug. 6 results will be followed by an 8 a.m. webcast - Stock Titan
Is Collegium Pharmaceutical Inc (COLL) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
Collegium Pharmaceutical Inc. (COLL) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Pharma Company Moving Headquarters From Suburbs To Downtown Boston - Bisnow
Collegium Pharmaceutical to relocate headquarters to Boston - Investing.com
DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln - Business Wire
Collegium Pharmaceutical to relocate headquarters to Boston By Investing.com - Investing.com Canada
After More Than 20 Years, Collegium Plans Boston Headquarters Move - Stock Titan
Collegium Pharmaceutical Inc. (COLL) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston - Sahm
Is Collegium Pharmaceutical (COLL) Still Undervalued As Its Growth Narrative Holds Up? - Yahoo Finance Singapore
Collegium Pharmaceutical Q1 2026 Earnings: EPS Surpasses Estimates by 8.43%Special Dividend Alert - dars.gov.et
COLL5756983 Bond Coupon Profile — Rate & Payments - TradingView
Collegium Pharmaceutical (COLL) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings## - simplywall.st
Form 144 COLLEGIUM PHARMACEUTICAL For: 17 July By Investing.com - Investing.com Nigeria
(COLL) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Planned sale of 13,920 COLL shares follows earlier 8,095-share disposal (COLL) - Stock Titan
enGene names Michael Heffernan board chairman as Richard Glickman steps down - Bitget
ETFs Investing in Collegium Pharmaceutical, Inc. Stocks - TradingView
COLL5756983 Bond Risk Profile - TradingView
COLL5756983 Bond Profile — Key Metrics - TradingView
US19459JAC8 Bond Coupon Profile — Rate & Payments - TradingView
US19459JAC8 Bond Risk Profile - TradingView
[144] COLLEGIUM PHARMACEUTICAL, INC SEC Filing - Stock Titan
Enterprise value to EBITDA forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
Collegium Pharmaceutical (COLL) Draws Fresh Valuation Attention, Is It Still A Bargain? - simplywall.st
4 defensive stocks to take refuge in as tech sell-off continues - MSN
Collegium Pharmaceutical stock gains 12% in three months: Here's why - MSN
Price to earnings forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? - Yahoo Finance
Price to book forward of Collegium Pharmaceutical, Inc. – NASDAQ:COLL - TradingView
New Strong Buy Stocks for July 6th - Yahoo Finance Singapore
Collegium Pharmaceutical Q1 2026 slides: ADHD growth drives earnings beat - Investing.com
Price to earnings forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
Enterprise value to EBITDA forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
Price to sales forward of Collegium Pharmaceutical, Inc. – FWB:354 - TradingView
COLLCollegium Pharmaceutical Inc Website Traffic and Mobile Apps Usage - Finviz
Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance? - simplywall.st
Collegium Pharmaceutical (COLL) Gains 3.2% as Stock Approaches Key ResistanceTurnaround Stocks - dars.gov.et
2 Profitable Stocks to Keep an Eye On and 1 We Brush Off - Yahoo Finance
Collegium Pharmaceutical Stock Gains 12% in Three Months: Here's Why - The Globe and Mail
Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $56 - Moomoo
Collegium (NASDAQ: COLL) details $655.6M AZSTARYS acquisition terms - Stock Titan
Collegium Pharmaceutical Inc (COLL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.30%
2.01%
자본화:
|
볼륨(24시간):